Resources

The Data Use Partnership (DUP) helped the Government of Tanzania identify a set of digital health investment recommendations with the highest potential value and alignment to national priorities. This report examines the unique factors of success in the development of Tanzania's Digital Health Investment Road Map. Included here is the full white paper, executive summary, and infographic examining this partnership and factors of success.

This brief outlines PATH's efforts to advance global health security and help stem the 2018 Ebola outbreak.

PATH has developed a protocol template as a guide for researchers who are planning an evaluation on a point of care G6PD diagnostic test.

PATH delivers statement at the 71st World Health Assembly on the implementation of international health regulations.

This report describes the evidence and policy needs of global and country decision-makers, public health program planners, and implementers that may be involved in maternal respiratory syncytial virus (RSV) vaccine decisions or delivery. The report focuses specifically on the context of potential introduction in low- and middle-income countries (LMICs) and summarizes relevant evidence across the following broad topic areas: 1) disease, 2) product, 3) health economics and financing, and 4) vaccine service delivery. Critical gaps in evidence are highlighted that, if left unfilled, could delay or preclude vaccine introduction in LMICs.Advancing Maternal Immunization (AMI) is a collaboration of cross-sectoral experts convened by PATH and WHO with the purpose of advancing RSV MI.